Specifically, in the framework of cancer-associated antigen detection, we chose to work with ssDNA-conjugated nanobody fragments, referred to as C8, optimized for the quantitative detection of the extracellular domain of the HER2 antigen, highly expressed in many types of cancer, including HER2 positive breast cancer (Figure 1). Here, ERBB2 is linked to breast carcinoma.